// App-Quantinova.ai

1456 : Synergistic Reversal of Arthritis By Synoviocyte-Targeted Therapy and TNF Immunomodulation

Researchers

Presenter

  • Christian Secchi

Principal Investigators

  • Mattias N. D. Svensson

  • Frances Humby

  • Rebecca Hands

  • Eugenio Santelli

  • Cristiano Sacchetti

  • Kuninobu Wakabayashi

  • Dennis J. Wu

  • Ardita Aliko

  • Piotr Mydel

  • Tsuyoshi Kasama

  • David L. Boyle

  • Francesco Galimi

  • Michel L. Tremblay

  • Gary S. Firestein

  • Costantino Pitzalis

  • Stephanie Standford

  • Nunzio Bottini

Medical Centers

  • University of California-San Diego, San Diego, CA

  • Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA

  • National Institute of Biostructures and Biosystems, University of Sassari, Sassari, Italy

  • Department of Medicine, University of California, La Jolla, CA

  • Centre for Endocrinology, Wiliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK

  • University of California, San Diego, La Jolla, CA

  • Div of Rheumatology, Showa University School of Med, Shinagawa-ku Tokyo, Japan

  • University of California-San Diego, San Diego, CA

  • University of Bergen, Bergen, Norway

  • Clinical Science, Broegelmann Research Laboratory, Bergen, Norway,

  • University of California, San Diego, La Jolla, CA

  • National Institute of Biostructures and Biosystems, University of Sassari, Sassari, Italy

  • Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada

  • La Jolla Institute for Allergy and Immunology, La Jolla, CA

Locations

  • United States

  • Italy

  • United Kingdom

  • Japan

  • Norway

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A